About Us

Vision & Values

Our Mission

CTI BioPharma is a biopharmaceutical company whose mission is to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. Our therapeutic focus is on novel targeted therapies covering a spectrum of blood-related cancers. We see patients as people, looking at potential therapies from the patient’s perspective to address both the clinical need and the impact treatment can have on a patient’s life. We prioritize the patient experience and are committed to developing therapeutic options for people living with cancer who want a chance at a longer and better quality of life.

Our Vision

To be the recognized leader in translating scientific discoveries into innovative therapies to cure patients with blood-related cancers.

Our Values

Our priority and sense of purpose is —the PATIENT. Our patient focus shapes our culture, organization and values.

Company success is dependent on our EMPLOYEES’ creativity and dedication. Without their talent, commitment and focus, we would not reach the ambitious goals we set for ourselves.

Our employees are dedicated to TEAMWORK. We have a true sense of ownership for our work and how it is tied directly to products that may significantly improve the outcome of patients’ lives.

We feel a responsibility to give back to our COMMUNITY. We contribute to numerous local organizations and support employee initiatives beyond the workplace.

The “patient first” focus gives us a greater understanding of our market—it is the key to serving our customers well and building SHAREHOLDER value.

You Are Leaving CTI BioPharma

You have selected a link to a third-party website. This link is provided solely as a convenience to you and not as an endorsement by CTI BioPharma of such third-party website. CTI BioPharma is not responsible for and does not make any representations regarding the accuracy of materials on such third-party site.

Continue to the Requested Site
Return to CTI BioPharma

Hello! We are pleased to announce that Cell Therapeutics has changed its name to

Enter Site